Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay: Determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer

Laine J. Murphey, Myles K. Williams, Stephanie C. Sanchez, Loretta M. Byrne, Ildiko Csiki, John A. Oates, David H. Johnson, Jason D. Morrow

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Prostaglandin (PG)E 2 is a major cyclooxygenase (COX) product that is important in human physiology and pathophysiology. Quantification of systemic PG production in humans is best assessed by measuring excreted urinary metabolites. Accurate and easy-to-perform assays to quantify the major urinary metabolite of PGE 2, 11α-hydroxy-9,15-dioxo-2,3,4,5-tetranor- prostane-1,20-dioic acid (PGE-M), do not exist. We now report the development of a robust and facile method to measure urinary PGE-M excretion in humans using stable isotope dilution techniques employing liquid chromatography/tandem mass spectrometry (LC/MS/MS). Concentrations of the metabolite in urine from healthy humans are nearly twofold greater in men than in women (10.4 ± 1.5 vs. 6.0 ± 0.7 ng/mg creatinine). Levels of PGE-M in healthy humans are suppressed significantly not only by the nonselective COX inhibitor ibuprofen but also by the COX-2 selective inhibitor rofecoxib, suggesting that the majority of PGE 2 formed in vivo is derived from COX-2. Increased COX-2 expression and increased PGE 2 production are associated with malignancy. Levels of PGE-M were found to be greatly increased in humans with unresectable non-small cell cancer of the lung, and this increase is dramatically reduced by administration of the COX-2 inhibitor celecoxib, implying that COX-2 contributes significantly to the overproduction of PGE 2. In summary, quantification of PGE-M using LC/MS/MS provides a facile and accurate method to assess PGE 2 formation in human physiological and pathophysiological processes.

Original languageEnglish (US)
Pages (from-to)266-275
Number of pages10
JournalAnalytical Biochemistry
Volume334
Issue number2
DOIs
StatePublished - Nov 15 2004

Fingerprint

Prostaglandin-Endoperoxide Synthases
Metabolites
Prostaglandins E
Assays
Lung Neoplasms
Cyclooxygenase 2
Liquids
Celecoxib
Cyclooxygenase 2 Inhibitors
Physiological Phenomena
Cyclooxygenase Inhibitors
Ibuprofen
Liquid chromatography
Physiology
Indicator Dilution Techniques
Isotopes
Dilution
Prostaglandins
Mass spectrometry
Tandem Mass Spectrometry

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay : Determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer. / Murphey, Laine J.; Williams, Myles K.; Sanchez, Stephanie C.; Byrne, Loretta M.; Csiki, Ildiko; Oates, John A.; Johnson, David H.; Morrow, Jason D.

In: Analytical Biochemistry, Vol. 334, No. 2, 15.11.2004, p. 266-275.

Research output: Contribution to journalArticle

Murphey, Laine J. ; Williams, Myles K. ; Sanchez, Stephanie C. ; Byrne, Loretta M. ; Csiki, Ildiko ; Oates, John A. ; Johnson, David H. ; Morrow, Jason D. / Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay : Determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer. In: Analytical Biochemistry. 2004 ; Vol. 334, No. 2. pp. 266-275.
@article{a996fdb40bdf4bbf9ade8254ca37d36d,
title = "Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay: Determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer",
abstract = "Prostaglandin (PG)E 2 is a major cyclooxygenase (COX) product that is important in human physiology and pathophysiology. Quantification of systemic PG production in humans is best assessed by measuring excreted urinary metabolites. Accurate and easy-to-perform assays to quantify the major urinary metabolite of PGE 2, 11α-hydroxy-9,15-dioxo-2,3,4,5-tetranor- prostane-1,20-dioic acid (PGE-M), do not exist. We now report the development of a robust and facile method to measure urinary PGE-M excretion in humans using stable isotope dilution techniques employing liquid chromatography/tandem mass spectrometry (LC/MS/MS). Concentrations of the metabolite in urine from healthy humans are nearly twofold greater in men than in women (10.4 ± 1.5 vs. 6.0 ± 0.7 ng/mg creatinine). Levels of PGE-M in healthy humans are suppressed significantly not only by the nonselective COX inhibitor ibuprofen but also by the COX-2 selective inhibitor rofecoxib, suggesting that the majority of PGE 2 formed in vivo is derived from COX-2. Increased COX-2 expression and increased PGE 2 production are associated with malignancy. Levels of PGE-M were found to be greatly increased in humans with unresectable non-small cell cancer of the lung, and this increase is dramatically reduced by administration of the COX-2 inhibitor celecoxib, implying that COX-2 contributes significantly to the overproduction of PGE 2. In summary, quantification of PGE-M using LC/MS/MS provides a facile and accurate method to assess PGE 2 formation in human physiological and pathophysiological processes.",
author = "Murphey, {Laine J.} and Williams, {Myles K.} and Sanchez, {Stephanie C.} and Byrne, {Loretta M.} and Ildiko Csiki and Oates, {John A.} and Johnson, {David H.} and Morrow, {Jason D.}",
year = "2004",
month = "11",
day = "15",
doi = "10.1016/j.ab.2004.08.019",
language = "English (US)",
volume = "334",
pages = "266--275",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Quantification of the major urinary metabolite of PGE 2 by a liquid chromatographic/mass spectrometric assay

T2 - Determination of cyclooxygenase-specific PGE 2 synthesis in healthy humans and those with lung cancer

AU - Murphey, Laine J.

AU - Williams, Myles K.

AU - Sanchez, Stephanie C.

AU - Byrne, Loretta M.

AU - Csiki, Ildiko

AU - Oates, John A.

AU - Johnson, David H.

AU - Morrow, Jason D.

PY - 2004/11/15

Y1 - 2004/11/15

N2 - Prostaglandin (PG)E 2 is a major cyclooxygenase (COX) product that is important in human physiology and pathophysiology. Quantification of systemic PG production in humans is best assessed by measuring excreted urinary metabolites. Accurate and easy-to-perform assays to quantify the major urinary metabolite of PGE 2, 11α-hydroxy-9,15-dioxo-2,3,4,5-tetranor- prostane-1,20-dioic acid (PGE-M), do not exist. We now report the development of a robust and facile method to measure urinary PGE-M excretion in humans using stable isotope dilution techniques employing liquid chromatography/tandem mass spectrometry (LC/MS/MS). Concentrations of the metabolite in urine from healthy humans are nearly twofold greater in men than in women (10.4 ± 1.5 vs. 6.0 ± 0.7 ng/mg creatinine). Levels of PGE-M in healthy humans are suppressed significantly not only by the nonselective COX inhibitor ibuprofen but also by the COX-2 selective inhibitor rofecoxib, suggesting that the majority of PGE 2 formed in vivo is derived from COX-2. Increased COX-2 expression and increased PGE 2 production are associated with malignancy. Levels of PGE-M were found to be greatly increased in humans with unresectable non-small cell cancer of the lung, and this increase is dramatically reduced by administration of the COX-2 inhibitor celecoxib, implying that COX-2 contributes significantly to the overproduction of PGE 2. In summary, quantification of PGE-M using LC/MS/MS provides a facile and accurate method to assess PGE 2 formation in human physiological and pathophysiological processes.

AB - Prostaglandin (PG)E 2 is a major cyclooxygenase (COX) product that is important in human physiology and pathophysiology. Quantification of systemic PG production in humans is best assessed by measuring excreted urinary metabolites. Accurate and easy-to-perform assays to quantify the major urinary metabolite of PGE 2, 11α-hydroxy-9,15-dioxo-2,3,4,5-tetranor- prostane-1,20-dioic acid (PGE-M), do not exist. We now report the development of a robust and facile method to measure urinary PGE-M excretion in humans using stable isotope dilution techniques employing liquid chromatography/tandem mass spectrometry (LC/MS/MS). Concentrations of the metabolite in urine from healthy humans are nearly twofold greater in men than in women (10.4 ± 1.5 vs. 6.0 ± 0.7 ng/mg creatinine). Levels of PGE-M in healthy humans are suppressed significantly not only by the nonselective COX inhibitor ibuprofen but also by the COX-2 selective inhibitor rofecoxib, suggesting that the majority of PGE 2 formed in vivo is derived from COX-2. Increased COX-2 expression and increased PGE 2 production are associated with malignancy. Levels of PGE-M were found to be greatly increased in humans with unresectable non-small cell cancer of the lung, and this increase is dramatically reduced by administration of the COX-2 inhibitor celecoxib, implying that COX-2 contributes significantly to the overproduction of PGE 2. In summary, quantification of PGE-M using LC/MS/MS provides a facile and accurate method to assess PGE 2 formation in human physiological and pathophysiological processes.

UR - http://www.scopus.com/inward/record.url?scp=5644272862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644272862&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2004.08.019

DO - 10.1016/j.ab.2004.08.019

M3 - Article

C2 - 15494133

AN - SCOPUS:5644272862

VL - 334

SP - 266

EP - 275

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 2

ER -